Status:
UNKNOWN
Effect of Ramosetron on Bowel Motility After Colorectal Resection
Lead Sponsor:
Kyunghee University Medical Center
Conditions:
Postoperative Nausea and Vomiting
Eligibility:
All Genders
20-70 years
Phase:
PHASE4
Brief Summary
Ramosetron is effective in preventing postoperative nausea and vomiting. Several studies reported that ramosetron is also effective treatment diarrhea-predominant irritable bowel syndrome. The investi...
Detailed Description
Ramosetron, a new potent and long-acting selective 5-HT3 receptor antagonist, is effective for preventing postoperative nausea and vomiting. Also several studies reported that ramosetron is effective ...
Eligibility Criteria
Inclusion
- 20-70 yr of age,
- ASA I or II,
- scheduled for laparoscopic colorectal surgery
Exclusion
- antiemetic use within 24hr prior to surgery
- steroid use within 24hr prior to surgery or 48hr after surgery
- insulin dependent DM
- cardiovascular or pulmonary disease
- renal or hepatic insufficiency
- BMI \>=35kg/m2
- pregnancy
Key Trial Info
Start Date :
December 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2011
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT01427127
Start Date
December 1 2010
End Date
December 1 2011
Last Update
September 1 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
School of Medicine, Kyung Hee University
Seoul, South Korea, 130-702